Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, inflammation, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Inflammation
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Expertises
        • Breakthroughs
        • Technologies
          • Clinical Translation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
        • Community and research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Career Opportunities
        • Student Opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
          • Healthy Recipes
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
          • Statements
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
          • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Over $4 million in grants to boost cancer research at the Centenary Institute

Over $4 million in grants to boost cancer research at the Centenary Institute

Date time 3 December, 2021
News Type News type Media release
From left: Prof Philip Hogg and Dr Jessamy Tiffen
Two Centenary Institute scientists have been awarded grants totalling $4.3 million from the Cancer Institute NSW to undertake critical cancer related medical research.

A major cause of illness, cancer is responsible for approximately 50,000 deaths each year in Australia.

The grants will enable world-leading research in two dedicated cancer areas. The first, the development of a new theranostic, a form of precision medicine, that is designed to work against all types of solid tumours.

The other, a new study investigating melanoma, to determine why men have twice the fatality rate of women when it comes to this deadliest form of skin cancer.

Funded Centenary Institute scientists and their research:

Professor Philip Hogg, Head, ACRF Centenary Cancer Research Centre.

Awarded a Translational Program Grant. $3.7 million over five years.

The grant will fund the development of a new theranostic that is designed to work against all types of cancers, becoming more effective with each administration. An emerging field, theranostics refers to a combined therapy and diagnostics approach. It involves the use of a diagnostic drug to first identify and label tumour cells – followed by the delivery of a therapeutic isotope (radioactive drug) to then kill the identified tumours.

Dr Jessamy Tiffen, Head, Melanoma Epigenetics Laboratory.

Awarded a Career Development Fellowship. $600,000 over three years.

The funding will look to determine why men are more than twice as likely to die from cancer as compared to women, specifically focusing on melanoma. Genes located on the X-chromosome will be comprehensively investigated to help explain this phenomenon and new melanoma treatments or interventions to improve survival outcomes in men will also be explored.

Professor Mathew Vadas AO, Centenary Institute Executive Director, said the successful grants were superb outcomes for two vital projects.

“Around 30% of Australians die of cancer with the disease also a leading cause of morbidity world-wide. It places a tremendous health burden on society,” said Professor Vadas.

“I congratulate both Professor Hogg and Dr Tiffen on their successful grants. They are both exceptional scientists and leaders in their fields. Each study will embrace the latest in advanced technologies and techniques, and has the potential to revolutionise cancer treatments, improving health and saving lives in our communities.”

Themes

  • Cancer Innovations

    Cancer Innovations

Laboratories

  • Tiffen

People

  • Professor Philip Hogg

    Faculty

  • Dr Jessamy Tiffen

    Acting Deputy Director
    Head, Centre for Cancer Innovations

Research Fields

  • Melanoma

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Over $4 million in grants to boost cancer research at the Centenary Institute

Download

Recent Stories

  • Serena Li, inaugural Chair of Centenary’s ReST Association

    Serena Li, a research assistant at the Centenary Institute, has recently been appointed as the Chair of the newly established ReST (Research Assistants, Support and Technicians) Association.
    News Type: Profiles
    Date 10 Jun 2025
  • Centenary Institute hosts TB research symposium

    The Centenary Institute has hosted the 2025 Annual Research Symposium of the ‘Centre of Research Excellence in Tuberculosis Elimination (TB-CRE)’.
    News Type: Events
    Date 02 Jun 2025
  • New discovery could improve treatment for people with haemophilia A

    Researchers from the Centenary Institute have uncovered a reason why some people with haemophilia A develop resistance to their critical treatment, paving the way for the development of more effective therapies.
    News Type: Media release
    Date 28 May 2025
  • New platform to evolve proteins for better therapies

    Researchers from the Centenary Institute, in collaboration with the University of Sydney, have developed a powerful new tool to evolve proteins directly within mammalian cells, offering a more effective way to design medical treatments tailored to the human body.
    News Type: Media release
    Date 08 May 2025

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram